Cure Biochem Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Cure Biochem General Information
Description
Manufacturer of glycolide and L-lactide chemical catering to medical industry. The company engages in basic chemicals that are forms in lives, as well as supply raw material for bio-industry and exporting from overseas markets for medical and industrial purposes for their continuous growth.
Contact Information
Website
www.curebc.kr(Operating Subsidiary)
Corporate Office
- 646-30, Hosu-ro
- Ilsandong-gu
- Goyang-si, Gyeonggi-do
- South Korea
Corporate Office
- 646-30, Hosu-ro
- Ilsandong-gu
- Goyang-si, Gyeonggi-do
- South Korea
Cure Biochem Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cure Biochem FAQs
-
When was Cure Biochem founded?
Cure Biochem was founded in 2018.
-
Where is Cure Biochem headquartered?
Cure Biochem is headquartered in Goyang-si, South Korea.
-
What industry is Cure Biochem in?
Cure Biochem’s primary industry is Pharmaceuticals.
-
Is Cure Biochem a private or public company?
Cure Biochem is a Private company.
-
What is the current valuation of Cure Biochem?
The current valuation of Cure Biochem is .
-
What is Cure Biochem’s current revenue?
The current revenue for Cure Biochem is .
-
When was Cure Biochem acquired?
Cure Biochem was acquired on 01-Sep-2023.
-
Who acquired Cure Biochem?
Cure Biochem was acquired by Meta Biomed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
